Pharmacotherapy of social phobias;Pharmakotherapie der Sozialen Phobie

Nervenheilkunde

Volumn 15, Issue 7, 1996, Pages 459-463

  Boerner, R J ^b   Moller H J ^a  

^a Ludwig Maximilians Universität ^*

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ATENOLOL; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROFAROMINE; BUSPIRONE; CITALOPRAM; CLONAZEPAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE;

DRUG THERAPY; HUMAN; PHOBIA; SHORT SURVEY; SOCIOPATHY;

EID: 0029855216     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (34)

1. Agras SW, Silvester D, Oliveau D. The epidemiology of common fears and phobias. Comprehensive Psychiatry 1969; 10: 439-47.
2. Bisserbe JC, Lepine JP, and the GRP Group. Moclobemide in social phobia: a pilot open study. Clin Neuropharmacol 1994; 17: 1: 588-94.
3. Black B, Uhde TW, Tancer ME. Fluoxetine for the treatment of social phobia. J Clin Psychopharmacol 1992; 12: 293-5.
4. Boerner RJ, Möller HJ. Therapie-Non-Response und Therapie-Resistenz bei Angststörungen: Definitionsmerkmale und Therapiemöglichkeiten. 1996 eingereicht in der Nervenheilkunde, Sonderheft.
5. Boerner RJ, Möller HJ. Zum Stellenwert von Kombinationstherapien bei Angststörungen. 1996 eingereicht in der Nervenheilkunde, Sonderheft.
6. Clark DB, Agras WS. The assessment and treatment of performance anxiety in musicians. Am J Psychiatry 1991; 148: 598-605.
7. Davidson JRT, Ford SM, Smith RD et al. Long-term treatment of social phobia with clonazepam. J Clin Psychiatry 1991; 52: 11: 16-20.
8. Davidson JRT, Potts N, Richichi E et al. Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 1993; 13: 6: 423-8.
9. Gerlernter CS, Uhde TW, Cimbolic P et al. Cognitive-behavioral and pharmacological treatment of social phobia: a controlled study. Arch Gen Psychiatry 1991; 48: 938-45.
10. Gorman JM, Liebowitz MR, Fyer AJ et al. Treatment of social phobia with atenolol. J Clin Psychopharmacol 1985; 5: 298-301.
11. Heimberg RE, Liebowitz MR, Hope DA, Schneier FS. Social Phobia. Diagnosis, Assessment, and Treatment. New York, London: The Guildford Press 1996.
12. Katzelnick DJ, Kobak KA, Greist JH et al. Sertraline in social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatry 1995; 152: 1368-71.
13. Kessler RC, McGonagle KH, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994; 51: 8-19.
14. Lepola U, Koponen H, Leinonen E. Citalopram in the treatment of social phobia: a report of three cases. Pharmacopsychiaty. 1994; 27: 186-8.
15. Liebowitz MR, Quitkin FM, Stewart JW et al. Phenelzine vs. imipramine in atypical depression. Arch Gen Psychiatry 1984; 41: 669-77.
16. Liebowitz MR, Fyer AJ, Gorman JM et al. Phenelzine in social phobia. J Clin Psychopharmacol 1986; 6: 93-8.
17. Liebowitz MR, Schneier F, Campeas R et al. Phenelzine vs atenolol in social phobia. Arch Gen Psychiatry 1992; 49: 290-300.
18. Munjack DJ, Bruns J, Baltazar PL et al. A pilot study of buspirone in the treatment of social phobia. J Anx Disord 1991; 5: 87-98.
19. Nutt D, Montgomery SA. Moclobemide in the treatment of social phobia. Int Clin Psychopharmacol 1996; 11: 3: 77-82.
20. Pollack MH, Otto MW. Long-term pharmacological treatment of panic disorder. Psychiatr Ann 1994; 24: 291-8.
21. Potts NLS, Book S, Davidson JRT. The neurobiology of social phobia. International Clin Psychopharmacol 1996; 11: 3: 43-8.
22. Reich J, Yates W. A pilot study of treatment of social phobia with alprazolam. Am J Psychiatry 1988; 145: 590-4.
23. Reiter SR, Pollack MH, Rosenbaum JF et al. Clonazepam for the treatment of social phobia. J Clin Psychiatry 1990; 51: 470-2.
24. Ringold AL. Paroxetine efficacy in social phobia (letter). J Clin Psychiatry 1994; 55: 262-4.
25. Schneier FR, Chin SJ, Hollander E et al. Fluoxetine in social phobia (letter) J Clin Psychopharmacol 1992; 12: 62-3.
26. Schneier FR, Saoud JB, Campeas R et al. Buspirone in social phobia. J Clin Psychopharmacol 1994; 13: 251-6.
27. Sternbach H. Fluoxetine treatment of social phobia (letter). J Clin Psychopharmacol 1990; 10: 230.
28. Van Ameringen M, Mancini C, Streiner D. Sertraline in social phobia. J Affect Disord 1994; 31: 141-5.
29. Van Ameringen M, Mancini C, Streiner DL. Fluoxetine efficacy in social phobia. J Clin Psychiatry 1993; 54: 27-32.
30. Van Vliet IM, den Boer JA, Westenberg GM. Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor. Eur Neuropsychopharmacol 1992; 2: 21-9.
31. Versiani M, Mundin FD, Nardi AE et al. Tranylcypromin in social phobia. J Clin Psychopharmacol 1988; 8: 279-83.
32. Versiani M, Nardi AE, Mundin FD et al. Pharmacotherapy in social phobia: a controlled study with moclobemide and phenelzine. Br J Psychiatry 1992; 161: 353-60.
33. Versiani M, Nardi AE, Mundim FD et al. The long-term treatment of social phobia with moelobemide. Int Clin Psychopharmacol 1996; 11: 3: 83-8.
34. Wittchen HU, Zhao S, Kessler RC. DSM-III-R Generalized Anxiety Disorder in the National Comorbidity Survey. Ann Arbor: Institute for Social Research 1993.